Related Experiment Videos
Group B streptococcal disease in pregnancy
1Department of Obstetrics/Gynecology, San Pablo Medical Center, Bayamon, Puerto Rico.
Insights
Group B Streptococcus (GBS) infection in newborns can lead to severe complications. Prompt diagnosis and treatment are crucial for improving outcomes in both mothers and infants affected by GBS.
Area of Science:
- Obstetrics and Gynecology
- Neonatology
- Infectious Diseases
Background:
- Group B Streptococcal (GBS) infection poses significant risks to neonates born to infected mothers.
- Maternal GBS colonization can result in serious neonatal infections with varying outcomes.
Observation:
- Presents three case reports detailing neonatal GBS infections with diverse clinical outcomes.
- Highlights the importance of understanding GBS microbiology and clinical presentations.
Findings:
- Early diagnosis and timely initiation of appropriate therapy are critical for managing GBS infections.
- Comprehensive review covers GBS history, microbiology, clinical manifestations, and current treatment guidelines.
Implications:
- Emphasizes the impact of early intervention on maternal and neonatal health outcomes in GBS cases.
- Informs clinical practice regarding the diagnosis and management of neonatal GBS infections.
Abstract:
Group B Streptococcal (GBS) infection in the pregnant female represents a challenging and often complex scenario which may cause deleterious effects in the neonate. In this paper we present three case reports of GBS infection in neonates with different outcome. A comprehensive review of the history, microbiology, clinical presentation and therapy guidelines is presented. Early diagnosis and institution of therapy are the most important factors which may have an impact on maternal and neonatal outcome.